EUVIMEDEUVIMED entdecken
Crossref

Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination

Hanzhen Zhang, Ruiying Chen, Mingyue Xu, Xiaoyun Huang, Wenqian Zhao, Jie Zhou, Min Zhang, Yunyu Xu, Da Shang, Qionghong Xie, Chuan-Ming Hao

Nephron · 2025

DOI: 10.1159/000544754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron, 2025. Verfasst von Hanzhen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, COVID-19 Vaccines, COVID-19. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although there have been reports of relapse or worsening of membranous nephropathy after receiving vaccines against coronavirus disease 2019 (COVID-19), the causal relationship or association between them has not been established. This study aimed to investigate the occurrence of relapse or worsening of membranous nephropathy following inactivated COVID-19 vaccination.

Methods

Patients who had been diagnosed with membranous nephropathy before receiving their first dose of vaccination, or before March 1, 2021, for unvaccinated patients, were included in the study. All patients were monitored at the Membranous Nephropathy Clinic of Huashan Hospital, Fudan University. The reasons for not receiving vaccines were investigated. The impact of COVID-19 vaccination on membranous nephropathy was assessed by comparing the relapse or worsening of membranous nephropathy within 12 months in vaccinated and unvaccinated patients with proteinuria

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousCOVID-19 VaccinesCOVID-19HumansMaleFemaleMiddle AgedRecurrenceAdultVaccines, InactivatedAgedProteinuriaVaccination

Stichwörter der Autor:innen

COVID-19Membranous nephropathyRelapseVaccinationWorsening of membranous nephropathy

Substanzen

COVID-19 VaccinesVaccines, Inactivated

Autor:innen und Institutionen

  • Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
  • Center for Systems Biology, Intelliphecy, Shenzhen, China.

Zitieren

APA

Zhang, H., Chen, R., Xu, M., Huang, X., Zhao, W., Zhou, J., Zhang, M., Xu, Y., Shang, D., Xie, Q., & Hao, C. M. (2025). Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination. Nephron. https://doi.org/10.1159/000544754

Vancouver

Zhang H, Chen R, Xu M, Huang X, Zhao W, Zhou J, et al. Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination. Nephron. 2025. doi:10.1159/000544754

BibTeX
@article{Zhang2025,
  author = {Zhang, Hanzhen and Chen, Ruiying and Xu, Mingyue and Huang, Xiaoyun and Zhao, Wenqian and Zhou, Jie and Zhang, Min and Xu, Yunyu and Shang, Da and Xie, Qionghong and Hao, Chuan-Ming},
  title = {Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination},
  journal = {Nephron},
  year = {2025},
  doi = {10.1159/000544754}
}
Kostenlos starten →